Type 2 diabetes: one disease, multiple cardiovascular risk factors

被引:51
作者
Calles-Escandon, J [1 ]
Garcia-Rubi, E [1 ]
Mirza, S [1 ]
Mortensen, A [1 ]
机构
[1] Univ Vermont, Dept Internal Med, Sect Endocrinol Diabet & Metab, Burlington, VT 05405 USA
关键词
vascular disease; diabetes; risk factors; insulin resistance;
D O I
10.1097/00019501-199901000-00004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes mellitus is a major independent risk factor for coronary artery disease. Atherosclerosis accounts for about 80% of all deaths from type 2 diabetes, of which roughly 75% ate attributable to coronary artery disease and the remainder to cerebrovascular or peripheral vascular events [1], The earlier onset and accelerated course of atherosclerosis in individuals with type 2 diabetes mellitus is multifactorial. Type 2 diabetes is associated with abnormalities in lipoprotein metabolism and increased propensity for oxidative damage. The hyperglycemia of patients with type 2 diabetes, in itself, may accelerate vascular damage. Type 2 diabetes is a hypercoagulable state attributable to enhanced coagulation and decreased fibrinolysis, as well as platelet hyperaggregability and endothelial dysfunction, Hypertension is common in individuals with type 2 diabetes and has a major impact in the accelerated atherosclerosis of this disease. This review provides an overview of selected aspects of these alterations. Coronary Artery Dis 10:23-30 (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:23 / 30
页数:8
相关论文
共 102 条
  • [1] ALESSI MC, 1988, THROMB HAEMOSTASIS, V60, P491
  • [2] Production of plasminogen activator inhibitor 1 by human adipose tissue - Possible link between visceral fat accumulation and vascular disease
    Alessi, MC
    Peiretti, F
    Morange, P
    Henry, M
    Nalbone, G
    JuhanVague, I
    [J]. DIABETES, 1997, 46 (05) : 860 - 867
  • [3] Baron AD, 1997, CIRCULATION, V96, P725
  • [4] INTRAPLATELET SEROTONIN IN PATIENTS WITH DIABETES-MELLITUS AND PERIPHERAL VASCULAR-DISEASE
    BARRADAS, MA
    GILL, DS
    FONSECA, VA
    MIKHAILIDIS, DP
    DANDONA, P
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1988, 18 (04) : 399 - 404
  • [5] DECREASED PLATELET PHOSPHOINOSITIDE TURNOVER AND ENHANCED PLATELET ACTIVATION IN IDDM
    BASTYR, EJ
    KADROFSKE, MM
    DERSHIMER, RC
    VINIK, AI
    [J]. DIABETES, 1989, 38 (09) : 1097 - 1102
  • [6] NONENZYMATIC GLYCOSYLATION PRODUCTS ON COLLAGEN COVALENTLY TRAP LOW-DENSITY LIPOPROTEIN
    BROWNLEE, M
    VLASSARA, H
    CERAMI, A
    [J]. DIABETES, 1985, 34 (09) : 938 - 941
  • [7] INHIBITION OF HEPARIN-CATALYZED HUMAN ANTITHROMBIN III ACTIVITY BY NONENZYMATIC GLYCOSYLATION - POSSIBLE ROLE IN FIBRIN DEPOSITION IN DIABETES
    BROWNLEE, M
    VLASSARA, H
    CERAMI, A
    [J]. DIABETES, 1984, 33 (06) : 532 - 535
  • [8] LIPID ADVANCED GLYCOSYLATION - PATHWAY FOR LIPID OXIDATION IN-VIVO
    BUCALA, R
    MAKITA, Z
    KOSCHINSKY, T
    CERAMI, A
    VLASSARA, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) : 6434 - 6438
  • [9] CAGLIERO E, 1991, J BIOL CHEM, V266, P14244
  • [10] Amelioration of the inhibition of fibrinolysis in elderly, obese subjects by moderate energy intake restriction
    CallesEscandon, J
    Ballor, D
    HarveyBerino, J
    Ades, P
    Tracy, R
    Sobel, B
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1996, 64 (01) : 7 - 11